Sort
39,280 grants matching “leukemia”
Molecular Cytogenetics Core
$326,193Anna Roschke · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Biospecimens and Primagraft Development
$326,180Jennifer R Brown · Dana-Farber Cancer Inst · P01 · FY2017 · CA
Strategies to Enhance Post-Transplant Tumor Vaccination
$326,165Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.
$326,161Todd A Fehniger · Washington University · P50 · FY2020 · CA
New Therapeutic Targets in AML
$326,135Jay L. Hess · University Of Michigan At Ann Arbor · R01 · FY2013 · CA
CYTOKINES CONVERT EPITHELIAL PRECURSORS TO NEPHRONS
$326,081Columbia University Health Sciences · R01 · FY2002 · DK
CYTOKINES CONVERT EPITHELIAL PRECURSORS TO NEPHRONS
$326,081Columbia University Health Sciences · R01 · FY2005 · DK
CYTOKINES CONVERT EPITHELIAL PRECURSORS TO NEPHRONS
$326,081Columbia University Health Sciences · R01 · FY2004 · DK
CYTOKINES CONVERT EPITHELIAL PRECURSORS TO NEPHRONS
$326,081Columbia University Health Sciences · R01 · FY2003 · DK
Temporal and Spatial Control of V(D)J Recombination
$326,066Stephen V Desiderio · Johns Hopkins University · R01 · FY2014 · CA
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)
$326,066Mary Y. Armanios · Johns Hopkins University · R01 · FY2014 · CA
Regulation of CARD11 signaling in normal and dysregulated lymphocyte development
$326,066Joel L Pomerantz · Johns Hopkins University · R01 · FY2014 · CA
Transposon Insertion Polymorphisms in Predispositions to Hematopoietic Neoplasia
$326,066Kathleen H Burns · Johns Hopkins University · R01 · FY2014 · CA
Microenvironment-Leukemia Communication Through Lectins
$326,066Nora C Heisterkamp · Children'S Hospital Of Los Angeles · R01 · FY2014 · CA
Structure/function studies of CTLD NK immunoreceptors
$326,057Fred Hutchinson Cancer Research Center · R01 · FY2005 · AI
PROLIFERATIVE EFFECTS OF HTLV1
$326,052Washington University · R01 · FY2000 · CA
Translational Studies Examining Soluble EPO Receptor and EPO Resistance in Dialys
$326,010Ravi Thadhani · Massachusetts General Hospital · R21 · FY2011 · HL
Role of Src kinases in NK lytic function
$326,000H. Lee Moffitt Cancer Ctr &Res Inst · R01 · FY2005 · CA
Role of Src kinases in NK lytic function
$326,000H. Lee Moffitt Cancer Ctr &Res Inst · R01 · FY2004 · CA
Drug Resistance in Multiple Myeloma
$326,000William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2007 · CA
A novel cilium-to-nucleus axis promotes cellular senescence
$325,950Jinghua Hu · Mayo Clinic Rochester · R01 · FY2023 · AG
A novel cilium-to-nucleus axis promotes cellular senescence
$325,950Jinghua Hu · Mayo Clinic Rochester · R01 · FY2024 · AG
A novel cilium-to-nucleus axis promotes cellular senescence
$325,950Jinghua Hu · Mayo Clinic Rochester · R01 · FY2022 · AG
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
$325,948Kevin M Shannon · University Of California, San Francisco · R01 · FY2013 · CA
Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia
$325,948Benjamin Braun · University Of California, San Francisco · R01 · FY2013 · CA